| Intrinsic Valuation of: CHTR | |||||||||||
| Free Cash Flow Average and Growth over past 5Y | Key Statistics | ||||||||||
| Year | FCF | FCF (FCF/Revenue) | |||||||||
| 2020 | - | - | EPS (FY) | 37 | Market Cap | $36B | |||||
| 2021 | - | - (-) | P/E Ratio | 7 | Total Asset | $150B | |||||
| 2022 | $9B | - (-) | Net Income | $5B | Total Debt | $93B | |||||
| 2023 | $6B | -36.1% (-38.9%) | EBITDA | $21B | Total Liab | $130B | |||||
| 2024 | $3B | -40.2% (-40.8%) | Opr Margin | 0.24 | Debt/Equity | 4.73 | |||||
| 2025 | $3B | -4.7% (-5.6%) | PreTax Margin | 14.55 | BV/Share | -604 | |||||
| 5Y Average FCF | $5B | -27.0% (-28.4%) | |||||||||
| Overall Market Assumptions: | |||||||||||
| Assumptions: | P/E for No-Growth Company: | 7.0 | |||||||||
| Perpetual Growth Rate (g): | 2.5% | Historical US Bond Yield: | 4.4% | ||||||||
| Discount Rate (WACC): | 7.4% | Current US Bond Yield: | 3.5% | ||||||||
| Forcasting Future Free Cash Flow for next 6Y | Modified Benjamin Graham's Intrinsic Value | ||||||||||
| Year | FCF Projection (4.0%) | ||||||||||
| 2026 | $3B | MBG Intrinsic Value | $327 | ||||||||
| 2027 | $3B | ||||||||||
| 2028 | $4B | ||||||||||
| 2029 | $4B | ||||||||||
| 2030 | $4B | ||||||||||
| 2031 | $4B | ||||||||||
| Terminal Value | $83B | Net Worth/Share | $144 | ||||||||
| DCF Valuation | DCF Valuation "What If" Scenario Table | ||||||||||
| Enterprise Value | $71B | Growth Rate | |||||||||
| (+) Cash & Cash Equivalents | $459M | $-159 | 1.5% | 2.0% | 2.5% | 3.0% | 3.5% | ||||
| (-) Total Debt | $93B | WACC | 7.3% | -221 | -188 | -148 | -99 | -37 | |||
| Equity Value | $-22B | 7.4% | -225 | -193 | -153 | -105 | -45 | ||||
| Shares Outstanding | 136,591,008 | 7.4% | -229 | -197 | -159 | -112 | -53 | ||||
| 7.9% | -264 | -238 | -207 | -170 | -124 | ||||||
| DCF Intrinsic Value | $-159 | 8.4% | -295 | -273 | -247 | -217 | -180 | ||||
| Analyzed by QuantJuice (2025) | |||||||||||